• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于遗传算法的有前途的适用于删失生存数据的亚组识别方法。

A promising subgroup identification method based on a genetic algorithm for censored survival data.

机构信息

Department of Epidemiology and Biostatistics, Public Health School, Harbin Medical University, Harbin, Heilongjiang, China.

Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.

出版信息

J Biopharm Stat. 2024 Jan 2;34(1):55-77. doi: 10.1080/10543406.2023.2170397. Epub 2023 Feb 1.

DOI:10.1080/10543406.2023.2170397
PMID:36727221
Abstract

Modern precision medicine requires drug development to account for patients' heterogeneity, as only a subgroup of the patient population is likely to benefit from the targeted therapy. In this paper, we propose a novel method for subgroup identification based on a genetic algorithm. The proposed method can detect promising subgroups defined by predictive biomarkers in which the treatment effects are much higher than the population average. The main idea is to search for the subgroup with the greatest predictive ability in the entire subgroup space via a genetic algorithm. We design a real-valued representation of subgroups that evolves according to a genetic algorithm and derive an objective function that properly evaluates the predictive ability of the subgroups. Compared with model- or tree-based subgroup identification methods, the distinctive search strategy of this new approach offers an improved capability to explore subgroups defined by multiple predictive biomarkers. By embedding a resampling scheme, the multiplicity and complexity issues inherent in subgroup identification methods can be addressed flexibly. We evaluate the performance of the proposed method in comparison with two other methods using simulation studies and a real-world example. The results show that the proposed method exhibits good properties in terms of multiplicity and complexity control, and the subgroups identified are much more accurate. Although we focus on the implementation of censored survival data, this method could easily be extended for the realization of continuous and categorical endpoints.

摘要

现代精准医学要求药物开发考虑患者的异质性,因为只有一小部分患者群体可能受益于靶向治疗。在本文中,我们提出了一种基于遗传算法的新的亚组识别方法。该方法可以检测出具有预测生物标志物的有前途的亚组,其中治疗效果明显高于人群平均水平。主要思想是通过遗传算法在整个亚组空间中搜索预测能力最强的亚组。我们设计了一种基于遗传算法进化的亚组实值表示,并推导出一种适当评估亚组预测能力的目标函数。与基于模型或树的亚组识别方法相比,这种新方法的独特搜索策略提供了一种改进的能力,可以探索由多个预测生物标志物定义的亚组。通过嵌入重采样方案,可以灵活地解决亚组识别方法中固有的多重性和复杂性问题。我们使用模拟研究和一个真实示例比较了所提出的方法与两种其他方法的性能。结果表明,所提出的方法在多重性和复杂性控制方面表现出良好的性能,并且识别出的亚组更加准确。虽然我们专注于实现有 censored 的生存数据,但该方法可以很容易地扩展到实现连续和分类终点。

相似文献

1
A promising subgroup identification method based on a genetic algorithm for censored survival data.一种基于遗传算法的有前途的适用于删失生存数据的亚组识别方法。
J Biopharm Stat. 2024 Jan 2;34(1):55-77. doi: 10.1080/10543406.2023.2170397. Epub 2023 Feb 1.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Subgroup identification for treatment selection in biomarker adaptive design.生物标志物适应性设计中用于治疗选择的亚组识别
BMC Med Res Methodol. 2015 Dec 9;15:105. doi: 10.1186/s12874-015-0098-7.
4
A nonparametric method for value function guided subgroup identification via gradient tree boosting for censored survival data.一种基于梯度提升树的非参数方法,通过价值函数引导亚组识别,用于处理删失生存数据。
Stat Med. 2020 Dec 10;39(28):4133-4146. doi: 10.1002/sim.8714. Epub 2020 Aug 12.
5
A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations.临床药物开发中亚组识别方法的比较:模拟研究与监管考量
Pharm Stat. 2019 Oct;18(5):600-626. doi: 10.1002/pst.1951. Epub 2019 Jul 3.
6
Subgroup identification based on differential effect search--a recursive partitioning method for establishing response to treatment in patient subpopulations.基于差异效应搜索的亚组识别——一种递归分区方法,用于建立患者亚组对治疗的反应。
Stat Med. 2011 Sep 20;30(21):2601-21. doi: 10.1002/sim.4289. Epub 2011 Jul 22.
7
Multiplicity issues in exploratory subgroup analysis.探索性子组分析中的多重性问题。
J Biopharm Stat. 2018;28(1):63-81. doi: 10.1080/10543406.2017.1397009. Epub 2017 Nov 27.
8
IBIS: identify biomarker-based subgroups with a Bayesian enrichment design for targeted combination therapy.IBIS:采用贝叶斯富集设计识别基于生物标志物的亚组,以进行靶向联合治疗。
BMC Med Res Methodol. 2023 Mar 20;23(1):66. doi: 10.1186/s12874-023-01877-w.
9
Strategies for identifying predictive biomarkers and subgroups with enhanced treatment effect in clinical trials using SIDES.在使用SIDES的临床试验中识别预测性生物标志物和具有增强治疗效果的亚组的策略。
J Biopharm Stat. 2014;24(1):130-53. doi: 10.1080/10543406.2013.856024.
10
CAPITAL: Optimal subgroup identification via constrained policy tree search.首都:通过受限策略树搜索进行最优子群识别。
Stat Med. 2022 Sep 20;41(21):4227-4244. doi: 10.1002/sim.9507. Epub 2022 Jul 7.